Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
Clinical trial NCT02660008 · COMPLETED
Trial details
- NCT number
- NCT02660008
- Sponsor
- Zealand Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-06-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.